Islet Autotransplantation to Preserve Beta Cell Mass in Selected Patients With Chronic Pancreatitis and Diabetes Mellitus Undergoing Total Pancreatectomy
- 1 March 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Pancreas
- Vol. 42 (2) , 317-321
Abstract
Objectives Islet autotransplantation (IAT) is performed in nondiabetic patients with chronic pancreatitis at the time of total pancreatectomy (TP) to minimize risk of postoperative diabetes. The role of TP-IAT in patients with chronic pancreatitis and C-peptide–positive diabetes is not established. We postulate that IAT can preserve beta cell mass and thereby benefit patients with preexisting diabetes undergoing TP. Methods Preoperative metabolic testing, islet isolation outcomes, and subsequent islet graft function were reviewed for 27 patients with diabetes mellitus and chronic pancreatitis undergoing TP-IAT. The relationships between the results of preoperative metabolic testing and islet isolation outcomes were explored using regression analysis. Results Mean islet yield was 2060 (SD, 2408) islet equivalents/kg. Peak C-peptide (from mixed meal tolerance testing) was the strongest predictor of islet yield, with higher stimulated C-peptide levels associated with greater islet mass. Half of the patients who had C-peptide levels measured after transplantation demonstrated C-peptide production at a level that conveys protective benefit in type 1 diabetes (≥0.6 ng/mL). Conclusions These findings provide proof of concept that significant islet mass can be isolated in patients with chronic pancreatitis and C-peptide–positive diabetes mellitus undergoing TP-IAT. Stimulated C-peptide may be a useful marker of islet mass before transplantation in these patients.Keywords
This publication has 17 references indexed in Scilit:
- Quality of Life Improves for Pediatric Patients After Total Pancreatectomy and Islet Autotransplant for Chronic PancreatitisClinical Gastroenterology and Hepatology, 2011
- Portal Vein Thrombosis Is a Potentially Preventable Complication in Clinical Islet TransplantationAmerican Journal of Transplantation, 2011
- Pediatric Islet Autotransplantation: Indication, Technique, and OutcomeCurrent Diabetes Reports, 2010
- Total pancreatectomy with islet autotransplantation: an overviewHPB, 2009
- Review: The importance of residual endogenous beta-cell preservation in type 1 diabetesBritish Journal of Diabetes, 2009
- Islet Autotransplant Outcomes After Total Pancreatectomy: A Contrast to Islet Allograft OutcomesTransplantation, 2008
- Protection of pancreatic beta-cells: Is it feasible?Nutrition, Metabolism and Cardiovascular Diseases, 2008
- The Role of Total Pancreatectomy and Islet Autotransplantation for Chronic PancreatitisSurgical Clinics of North America, 2007
- Islet cell failure in type 2 diabetesJournal of Clinical Investigation, 2006
- Metabolic Consequences of (Regional) Total PancreatectomyAnnals of Surgery, 1991